Drug therapy for torsade de pointes

Area of Science:

• Cardiology
• Electrophysiology

Background:

• Torsade de pointes (TdP) is a distinct form of ventricular tachycardia with unique characteristics.
• It is crucial to recognize TdP as standard treatments can be ineffective or harmful.

Purpose of the Study:

• To highlight the importance of identifying TdP.
• To discuss its precipitating factors and effective treatment strategies.

Main Methods:

• Review of TdP's morphological features, underlying mechanisms, and therapeutic approaches.
• Identification of predisposing factors such as drug induction and electrolyte imbalances.

Main Results:

• TdP is often precipitated by QT-prolonging drugs and electrolyte imbalances.
• Therapies like isoproterenol, pacing, and atropine are used, but magnesium sulfate is highly effective.

Conclusions:

• Prompt recognition of TdP is vital for appropriate management.
• Intravenous magnesium sulfate is the treatment of choice for TdP, effectively shortening the QT interval and preventing recurrence.